Politics
FDA approves first daily pill to drastically lower cholesterol levels
The Hill·July 16, 2026·1 min read
The FDA approved Lipfendra, a first-of-its-kind once-daily cholesterol pill from Merck. The drug reduces "bad" LDL cholesterol by inhibiting PCSK9 protein production. Lipfendra rivals the effectiveness of existing powerful drugs. This marks the first approval of a daily oral PCSK9 inhibitor for lowering cholesterol in adults.
Read at The HillDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.